Introductory paper: High-dose influenza vaccine.

Mia Diaco, Lee-Jah Chang, Bruce Seet, Corey A Robertson, Ayman Chit, Monica Mercer, David P Greenberg, Rosalind Hollingsworth, Sandrine I Samson

Vaccine 2021 Mar 15

filter terms:

Seasonal influenza has a significant impact on global public health each year, especially in older adults 65 years of age and above. This paper presents the evolution of high-dose influenza vaccine and the quantity as well as quality of evidence on this vaccine. Its introduces other peer-reviewed manuscripts included in this supplement covering the benefits high-dose influenza vaccine over ten consecutive influenza seasons. The development of the high-dose influenza vaccine represents an important step in the evolution of influenza vaccines, offering an advancement in prevention of influenza and a step in encouraging healthy aging in older adults. A video summary of the article can be accessed via the Supplementary data link at the end of this article. Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Citation

Mia Diaco, Lee-Jah Chang, Bruce Seet, Corey A Robertson, Ayman Chit, Monica Mercer, David P Greenberg, Rosalind Hollingsworth, Sandrine I Samson. Introductory paper: High-dose influenza vaccine. Vaccine. 2021 Mar 15;39 Suppl 1:A1-A5